Droxidopa and Reduced Falls in a Trial of Parkinson Disease Patients With Neurogenic Orthostatic Hypotension

OBJECTIVES: Droxidopa is a prodrug of norepinephrine indicated for the treatment of orthostatic dizziness, lightheadedness, or the “feeling that you are about to black out” in adult patients with symptomatic neurogenic orthostatic hypotension caused by primary autonomic failure including Parkinson d...

Descripción completa

Detalles Bibliográficos
Autores principales: Hauser, Robert A., Heritier, Stephane, Rowse, Gerald J., Hewitt, L. Arthur, Isaacson, Stuart H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028156/
https://www.ncbi.nlm.nih.gov/pubmed/27332626
http://dx.doi.org/10.1097/WNF.0000000000000168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028156/
https://www.ncbi.nlm.nih.gov/pubmed/27332626
http://dx.doi.org/10.1097/WNF.0000000000000168

Ejemplares similares